Company intelligence / Profile preview

Aqua Pharma

Norway

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Aqua Pharma has successfully deployed its proprietary bath treatment systems for controlling sea lice and other aquaculture diseases in multiple countries. Its hydrogen peroxide-based bath treatments are well-established and highly regarded for fish welfare, with ongoing technology and dosing innovations

Therapeutic areas: Infectious Diseases
Modalities: Bath treatment (Hydrogen peroxide/oxygenated water-based)Water conditioningOxygenation solutions
Industry: Veterinary

Partnerships

Solvay (relation: joint venture partner and technology provider)Aquatiq (relation: joint venture partner)

Beyond the preview

Go deeper on Aqua Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aqua Pharma.

Explore the full profile